Biomarkers for the prediction of responsiveness to clozapine treatment

Details for Australian Patent Application No. 2005250142 (hide)

Owner Novartis AG

Inventors He, Yunsheng; Leroy, Elisabeth Marie

Agent Davies Collison Cave

Pub. Number AU-B-2005250142

PCT Pub. Number WO2005/118848

Priority 60/577,131 04.06.04 US

Filing date 3 June 2005

Wipo publication date 15 December 2005

Acceptance publication date 21 August 2008

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/118848 Priority application(s): WO2005/118848

21 August 2008 Application Accepted

  Published as AU-B-2005250142

18 December 2008 Standard Patent Sealed

6 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005250146-HIV type and subtype detection

2005250124-Butyrylcholinesterase selective inhibitors